Tenderwize
Zurück zur Suche

Delivery of Medicinal Products for the Needs of SBALHZ EAD

СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ НА ХЕМАТОЛОГИЧНИ ЗАБОЛЯВАНИЯ ЕАД·гр. София, Bulgaria·BGN 42.5M·Deadline Jun 07, 2027 · 285 days left·Restricted·Supplies·DPS
Registrieren zum SpeichernOpen documents
Structured notice only
Originaltitel der Bekanntmachung

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на СБАЛХЗ ЕАД

75/100

Opportunity Score

PromisingMedium complexity
SuppliesDPSOpen
Warum diese Bewertung?

Chance

75 / 100

Komplexität

50 / 100

Risikofaktoren

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • BGN 42.5M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of pharmaceutical products for a hematology hospital
  • Dynamic Purchasing System (DPS) with possible additions/changes to product list
Vollständige Zusammenfassung anzeigen

This tender is a Dynamic Purchasing System (DPS) for the supply of various pharmaceutical products to the Specialized Hospital for Active Treatment of Hematological Diseases (SBALHZ EAD) in Sofia, Bulgaria. The DPS has a duration of 24 months with a total estimated value of 42,451,813.04 BGN. The procedure is restricted and divided into one lot. Award is based on the lowest price per nomenclature item. Participation requires valid licenses for pharmaceutical production or wholesale, and a narcotic drugs license if applicable. The DPS is open for applications until 7 June 2027. Note: There is an inconsistency regarding EU funding; structured data indicates EU-funded, but the XML notice states no EU funds.

Risiken

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must hold valid authorization for manufacture or wholesale of medicinal products (or equivalent for EU/EEA)

Eligibility

  • Declaration of eligibility via ESPD (European Single Procurement Document) in Part IV A

Certifications

  • Must hold narcotic drugs license if offering such products

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Lowest price per nomenclature item.

Auftraggeber

Ort

гр. София, BGR

Auftraggeberprofil

Profil öffnen

Kennung

200105779

Tätigkeit

Health

Lose (1)

LOT-0001

Delivery of Medicinal Products for the Needs of SBALHZ EAD

Supply of various medicinal products as detailed in the technical specification (International Nonproprietary Names, active substance quantity, pharmaceutical form, estimated quantities, and estimated values). The specification may be partially amended during the DPS by adding new products or changing quantities.

SuppliesDPSEU fundedElectronic submission

BGN 42.5M

Geschätzter Wert

Ort

София, Bulgaria

Dauer

Jun 2025

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Frist

Deadline Jun 07, 2027

Vergabedetails

Veröffentlichungsdatum
04 Jun 2025
Sprachen
Bulgarian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
363187-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3